Abstract:Osteoporosis is a major global health issue, weakening bones and increasing fracture risk. Dual-energy X-ray absorptiometry (DXA) is the standard for measuring bone mineral density (BMD) and diagnosing osteoporosis, but its costliness and complexity impede widespread screening adoption. Predictive modeling using genetic and clinical data offers a cost-effective alternative for assessing osteoporosis and fracture risk. This study aims to develop BMD prediction models using data from the UK Biobank (UKBB) and test their performance across different ethnic and geographical populations. We developed BMD prediction models for the femoral neck (FNK) and lumbar spine (SPN) using both genetic variants and clinical factors (such as sex, age, height, and weight), within 17,964 British white individuals from UKBB. Models based on regression with least absolute shrinkage and selection operator (LASSO), selected based on the coefficient of determination (R 2 ) from a model selection subset of 5,973 individuals from British white population. These models were tested on 5 UKBB test sets and 12 independent cohorts of diverse ancestries, totaling over 15,000 individuals. Furthermore, we assessed the correlation of predicted BMDs with fragility fractures risk in 10 years in a case-control set of 287,183 European white participants without DXA-BMDs in the UKBB. With single-nucleotide polymorphism (SNP) inclusion thresholds at 5×10 −6 and 5×10 −7 , the prediction models for FNK-BMD and SPN-BMD achieved the highest R 2 of 27.70% with a 95% confidence interval (CI) of [27.56%, 27.84%] and 48.28% (95% CI [48.23%, 48.34%]), respectively. Adding genetic factors improved predictions slightly, explaining an additional 2.3% variation for FNK-BMD and 3% for SPN-BMD over clinical factors alone. Survival analysis revealed that the predicted FNK-BMD and SPN-BMD were significantly associated with fragility fracture risk in the European white population ( P < 0.001). The hazard ratios (HRs) of the predicted FNK-BMD and SPN-BMD were 0.83 (95% CI [0.79, 0.88], corresponding to a 1.44% difference in 10-year absolute risk) and 0.72 (95% CI [0.68, 0.76], corresponding to a 1.64% difference in 10-year absolute risk), respectively, indicating that for every increase of one standard deviation in BMD, the fracture risk will decrease by 17% and 28%, respectively. However, the model's performance declined in other ethnic groups and independent cohorts. The limitations of this study include differences in clinical factors distribution and the use of only SNPs as genetic factors. In this study, we observed that combining genetic and clinical factors improves BMD prediction compared to clinical factors alone. Adjusting inclusion thresholds for genetic variants (e.g., 5×10 −6 or 5×10 −7 ) rather than solely considering genome-wide association study (GWAS)-significant variants can enhance the model's explanatory power. The study highlights the need for training models on diverse populations to improve predictive performance across various ethnic and geographical groups.

Genomic structural variations link multiple genes to bone mineral density in a multi-ethnic cohort study: Louisiana osteoporosis study

A Multiethnic Whole Genome Sequencing Study to Identify Novel Loci for Bone Mineral Density.

Integrative Genomic Analysis Predicts Novel Functional Enhancer-Snps for Bone Mineral Density

Gene-based Association Analysis Identified Novel Genes Associated with Bone Mineral Density.

Multistage genome-wide association meta-analyses identified two new loci for bone mineral density.

Complex segregation analyses of bone mineral density in Chinese.

Meta-Analysis of Genome-Wide Association Studies Identifies Novel Functional CpG-SNPs Associated with Bone Mineral Density at Lumbar Spine.

Exome-wide Screening Identifies Novel Rare Risk Variants for Bone Mineral Density

Evidence for Major Pleiotropic Effects on Bone Size Variation from a Principal Component Analysis of 451 Caucasian Families

Genetic Variants Affecting Bone Mineral Density and Bone Mineral Content at Multiple Skeletal Sites in Hispanic Children

Integration of Summary Data from GWAS and Eqtl Studies Identified Novel Causal BMD Genes with Functional Predictions.

Contribution Of Genotype And Ethnicity To Bone Mineral Density Variation In Caucasians And Chinese: A Test For Five Candidate Genes For Bone Mass

Twelve Loci Associated With Bone Density in Middle-aged and Elderly Chinese: The Shanghai Changfeng Study

Identifying Rare Genetic Determinants for Improved Polygenic Risk Prediction of Bone Mineral Density and Fracture Risk

A Transcriptome-Wide Association Study to Detect Novel Genes for Volumetric Bone Mineral Density

Genome-wide Association Study of Lncrna Polymorphisms with Bone Mineral Density

Erratum to: Genome-wide copy number variation association study suggested VPS13B gene for osteoporosis in Caucasians

Pleiotropic Loci Underlying Bone Mineral Density and Bone Size Identified by a Bivariate Genome-Wide Association Analysis

Association of Jag1 with Bone Mineral Density and Osteoporotic Fractures: A Genome-Wide Association Study and Follow-Up Replication Studies

Variability in performance of genetic-enhanced DXA-BMD prediction models across diverse ethnic and geographic populations: A risk prediction study

Are Bone Mineral Density Loci Associated with Hip Osteoporotic Fractures? A Validation Study on Previously Reported Genome-Wide Association Loci in a Chinese Population